What’s new

• Revenue grew 36% YoY to ₹1,207 cr in Q4 FY26; net profit rose 30%.
• New Delhi and Faridabad units now generate 11% of group revenue.
• Signed deal to acquire a 250-bed hospital in Gurugram, to close by April 2027.

Why it matters

The 36% top-line growth is fueled by new facilities ramping faster than expected. The Gurugram acquisition is the next concrete step toward the ambitious 5,000-bed target, providing a pipeline beyond organic expansion.

What we’re watching

• Execution on the Gurugram acquisition and integration timeline.
• Whether debtor days actually fall to the guided 90-95 day range.
• Margin discipline as the company scales capacity rapidly.

The full read

Yatharth Hospital's Q4 FY26 transcript confirms the strong operational story behind the numbers. Revenue hit ₹1,207 crore, up 36% YoY, with net profit growing 30%. The key driver was the faster-than-expected scale-up of new facilities in Delhi and Faridabad, which now generate 11% of group revenue. Management is pushing the growth pedal further with a 250-bed acquisition in Gurugram, slated to close by April 2027, as part of a broader target to reach 5,000 beds in three years. On profitability, the guidance is for 24-25% EBITDA margins and a push to cut debtor days to 90-95. The Gurugram deal turns the 5,000-bed target from a talking point into a funded plan.

Primary source: BSE · NSE

What’s new

• Agra hospital ARPOB stalled at ₹26,000-27,000, missing the ₹30,000 target.
• Brownfield expansions in Greater Noida and Noida Extension are delayed.
• Income tax resolution pushed to end-Q2 FY27 from the previous FY26 deadline.

Why it matters

Management is maintaining ambitious growth targets despite operational friction. The failure to hit ARPOB goals in Agra and the timeline slippage on brownfield projects suggest that scaling is proving more difficult than initially projected.

What we’re watching

• The April 2027 opening date for the new Gurugram hospital.
• Progress on the 5,000-bed expansion plan funded by internal accruals.
• Resolution of the pending income tax matter by Q2 FY27.

The full read

Yatharth Hospital is betting on 26% revenue growth for FY27, but the path to that figure is getting complicated. During its recent conference call, management admitted that the Agra facility is underperforming, with ARPOB stuck at ₹26,000-27,000 against a ₹30,000 target. Expansion efforts are also hitting delays, specifically at the Greater Noida and Noida Extension brownfield sites.

Growth is stalling.

While the company maintains its 24-25% EBITDA margin guidance and sticks to its 5,000-bed expansion roadmap, the timeline for resolving a long-standing income tax dispute has slipped to Q2 FY27. The company plans to fund its growth through internal accruals, with the Gurugram hospital still slated for April 2027. The gap between the ambitious growth targets and the current operational delays is the primary tension point for investors to monitor as the company attempts to scale its footprint.

Primary source: BSE · NSE